7th CB1, CB2 & Cannabinoid Drug Development Summit

This Event has Passed

Monday, November 18, 2024 - 9:00 AM
to Wednesday, November 20, 2024 - 5:00 PM

Add to Calendar

11/18/2024 09:00 AM 11/20/2024 05:00 PM America/Anguilla 7th CB1, CB2 & Cannabinoid Drug Development Summit As drug developers continue to utilize the expedited FDA regulatory pathway available for CBD, alongside a growing interest in the therapeutic benefits and regulatory approval of novel cannabinoids, the cannabinoid drug development landscape is rapidly evolving. Additionally, innovative preclinical candidates targeting CB1 and CB2 receptors are advancing through the pipeline, as developers aim to secure regulatory approval for treatments addressing weight management, pain, neurological conditions, and more. The field continues to grow, with both phytocannabinoid and synthetic drug candidates aspiring to achieve milestones like those set by Epidiolex, Marinol, Syndros, and Cesamet. Join 60+ ... Details & Tickets: https://www.upcomingevents.com/boston/events/wyndham-boston-beacon-hill/7th-cb1-cb2-cannabinoid-drug-development-summit-297299?ref=uceaddevent Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, MA, 02114

Neighborhoods

Beacon Hill (Boston)
Downtown Crossing (Boston)
Government Center (Boston)
West End (Boston)

View Event Website »

As drug developers continue to utilize the expedited FDA regulatory pathway available for CBD, alongside a growing interest in the therapeutic benefits and regulatory approval of novel cannabinoids, the cannabinoid drug development landscape is rapidly evolving. Additionally, innovative preclinical candidates targeting CB1 and CB2 receptors are advancing through the pipeline, as developers aim to secure regulatory approval for treatments addressing weight management, pain, neurological conditions, and more. The field continues to grow, with both phytocannabinoid and synthetic drug candidates aspiring to achieve milestones like those set by Epidiolex, Marinol, Syndros, and Cesamet. Join 60+ experts from discovery, preclinical, translational, regulatory, clinical, and chemistry fields at the 7th CB1, CB2, & Cannabinoid Drug Development Summit as they work to unlock the potential of CB1, CB2, and cannabinoid drugs for treating obesity, pain, inflammation, CNS disorders, and rare diseases.

Event Links

Website: https://go.evvnt.com/2621613-0

Tickets: https://go.evvnt.com/2621613-1

Brochure: https://go.evvnt.com/2621613-3

View Less